Details of Protein
General Information of Protein (ID: PRT01559) | |||||
---|---|---|---|---|---|
Name | Phosphoglycerate dehydrogenase (PHGDH) | ||||
Synonyms |
Click to Show/Hide Synonyms of This Protein
3-PGDH; 2-oxoglutarate reductase; Malate dehydrogenase; PHGDH; PGDH3
|
||||
Gene Name | PHGDH | Gene ID | |||
UniProt ID | |||||
Family | Oxidoreductases (EC 1) | ||||
EC Number | EC: 1.1.1.95 (Click to Show/Hide the Complete EC Tree) | ||||
Click to Show/Hide the Molecular/Functional Data (Sequence/Structure/Function) of This Protein | |||||
Sequence |
MAFANLRKVLISDSLDPCCRKILQDGGLQVVEKQNLSKEELIAELQDCEGLIVRSATKVT
ADVINAAEKLQVVGRAGTGVDNVDLEAATRKGILVMNTPNGNSLSAAELTCGMIMCLARQ IPQATASMKDGKWERKKFMGTELNGKTLGILGLGRIGREVATRMQSFGMKTIGYDPIISP EVSASFGVQQLPLEEIWPLCDFITVHTPLLPSTTGLLNDNTFAQCKKGVRVVNCARGGIV DEGALLRALQSGQCAGAALDVFTEEPPRDRALVDHENVISCPHLGASTKEAQSRCGEEIA VQFVDMVKGKSLTGVVNAQALTSAFSPHTKPWIGLAEALGTLMRAWAGSPKGTIQVITQG TSLKNAGNCLSPAVIVGLLKEASKQADVNLVNAKLLVKEAGLNVTTSHSPAAPGEQGFGE CLLAVALAGAPYQAVGLVQGTTPVLQGLNGAVFRPEVPLRRDLPLLLFRTQTSDPAMLPT MIGLLAEAGVRLLSYQTSLVSDGETWHVMGISSLLPSLEAWKQHVTEAFQFHF |
||||
Structure | |||||
Function | Catalyzes the reversible oxidation of 3-phospho-D-glycerate to 3-phosphonooxypyruvate, the first step of the phosphorylated L-serine biosynthesis pathway. Also catalyzes the reversible oxidation of 2-hydroxyglutarate to 2-oxoglutarate and the reversible oxidation of (S)-malate to oxaloacetate. | ||||
Regulatory Network | |||||
Full List of Metabolite(s) Regulated by This Protein | ||||||
---|---|---|---|---|---|---|
Organic acids and derivatives | ||||||
Glycine | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Overexpression of PHGDH | |||||
Induced Change | Glycine concentration: increase | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Breast cancer [ICD-11: 2C60] | |||||
Details | It is reported that overexpression of PHGDH leads to the increase of glycine levels compared with control group. | |||||
Phosphoserine | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Knockout of PHGDH | |||||
Induced Change | Phosphoserine concentration: decrease | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that knockout of PHGDH leads to the decrease of phosphoserine levels compared with control group. | |||||
Serine | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[2] | ||||
Introduced Variation | Overexpression of PHGDH | |||||
Induced Change | Serine concentration: increase | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Breast cancer [ICD-11: 2C60] | |||||
Details | It is reported that overexpression of PHGDH leads to the increase of serine levels compared with control group. | |||||
Full List of Metabolite(s) Regulating This Protein | ||||||
---|---|---|---|---|---|---|
Organic acids and derivatives | ||||||
Glutamine | Click to Show/Hide the Full List of Regulating Pair(s): 2 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair (1) |
Experim Info
![]() |
[3] | ||||
Introduced Variation | Glutamine decrease (48 hours) | |||||
Induced Change | PHGDH protein expression levels: increase | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Cervical Cancer [ICD-11: 2C77] ... | |||||
Details | It is reported that glutamine decrease causes the increase of PHGDH protein expression compared with control group. | |||||
Regulating Pair (2) |
Experim Info
![]() |
[3] | ||||
Introduced Variation | Glutamine decrease (48 hours) | |||||
Induced Change | PHGDH mRNA levels: increase | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Cervical Cancer [ICD-11: 2C77] ... | |||||
Details | It is reported that glutamine decrease causes the increase of PHGDH mRNA levels compared with control group. | |||||
Organic oxygen compounds | ||||||
Glucose | Click to Show/Hide the Full List of Regulating Pair(s): 2 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair (1) |
Experim Info
![]() |
[3] | ||||
Introduced Variation | Glucose decrease (48 hours) | |||||
Induced Change | PHGDH protein expression levels: increase | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Hepatocellular carcinoma [ICD-11: 2C12] | |||||
Details | It is reported that glucose decrease causes the increase of PHGDH protein expression/PHGDH mRNA levels compared with control group. | |||||
Regulating Pair (2) |
Experim Info
![]() |
[3] | ||||
Introduced Variation | Glucose decrease (48 hours) | |||||
Induced Change | PHGDH mRNA levels: increase | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Hepatocellular carcinoma [ICD-11: 2C12] | |||||
Details | It is reported that glucose decrease causes the increase of PHGDH mRNA levels compared with control group. | |||||
Phenylpropanoids and polyketides | ||||||
Tetracycline | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[3] | ||||
Introduced Variation | Tetracycline addition (24 hours) | |||||
Induced Change | PHGDH protein expression levels: decrease | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Acute lymphoblastic leukemia [ICD-11: 2B33] | |||||
Details | It is reported that tetracycline addition causes the decrease of PHGDH protein expression compared with control group. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang and Dr. Mou.